
This episode features Martine Rothblatt, CEO of United Therapeutics, discussing her life, career, and innovations in biotechnology. Key topics include her journey as a transgender woman, her leadership style, and the development of manufactured organs.
Martine Rothblatt shares her background as a lawyer, author, and entrepreneur, emphasizing her motivation to found United Therapeutics to save her daughter’s life from pulmonary arterial hypertension. She reflects on her proudest accomplishment being her family.
Rothblatt describes her typical week as a CEO, highlighting her approach to leadership through engagement with employees and collaboration on scientific challenges. She explains the importance of questioning decisions while delegating technical details to experts.
The conversation shifts to the concept of manufactured organs, with Rothblatt discussing the potential for lung transplantation and xenotransplantation as a solution for organ shortages. She believes that manufactured organs could revolutionize treatment for diseases like pulmonary hypertension.
Finally, Rothblatt introduces her book, "Virtually Human," which explores digital immortality and the implications of AI and big data on human consciousness. She discusses the potential for mind clones and their impact on society, ethics, and the future of human interaction.
Martine Rothblatt discusses her life, leadership, and the future of biotechnology and digital immortality.

This episode stands out for the following:
I just wanted to save my daughter.The Promise and Peril of Digital Mortality
Digital immortality is a wild thought.The Promise and Peril of Digital Mortality
We will be able to talk to ourselves outside of ourselves.The Promise and Peril of Digital Mortality
Pain is pain and pain is bad.The Promise and Peril of Digital Mortality
I believe that it will democratize faster than any technology in history.The Promise and Peril of Digital Mortality